Providing clinicians with enterprise-wide data analysis of information stored in an Oracle-supported database, Misys Data Warehouse 4.0 features 80 different enhancements to optimize analysis of information supplied from Misys CPR.

Product enhancements in version 4.0 expand data extraction functionality, reporting capabilities and product utilities for an improved user experience and database management. Extracting information for Misys Data Warehouse allows clinicians to evaluate procedures across all patients in all departments.

Providing clinicians with enterprise-wide data analysis of information stored in an Oracle-supported database, Misys Data Warehouse 4.0 features 80 different enhancements to optimize analysis of information supplied from Misys CPR.

Product enhancements in version 4.0 expand data extraction functionality, reporting capabilities and product utilities for an improved user experience and database management. Extracting information for Misys Data Warehouse allows clinicians to evaluate procedures across all patients in all departments.

CD Wipeout addresses the needs of hospitals and imaging centers that transition to a digital environment for image and record creation, distribution and storage and now require a way to properly destroy CDs that were burned with patient data. Whether a staff member inadvertently burns too many copies of a patient CD, or perhaps even a partially burned, rejected CD, a disc may have some level of patient data and therefore requires proper destruction.

Feb. 6, 2007 — The FDA has issued an approval letter for GlaxoSmithKline’s once-a-day anticoagulant, Arixtra (fondaparinux sodium) Injection for the treatment of patients with: unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI); ST-segment elevation myocardial infarction (STEMI); UA/NSTEMI and STEMI are types of acute coronary syndromes (ACS).

Feb. 6, 2007 — The Centers for Medicare and Medicaid Services (CMS) has released new proposed policy in which coverage for carotid artery stenting (CAS) would be expanded. The National Coverage Determinaton (NCD) would encompass an asymptomatic patient population (approximately 70 percent of patients).

Feb. 1, 2007 — Stockholders of Conor Medsystems, Inc. have approved the merger agreement between Conor and Johnson & Johnson and a wholly owned subsidiary of Johnson & Johnson, according to a release from Conor Medsystems today. The proposed transaction is expected to close within the next few days, subject to the satisfaction of the remaining closing conditions

Feb. 1, 2007 — Cook Medical released nine-month data this week for its PTX Paclitaxel-Eluting Stent (DES) trial, which to date demonstrate no stent fractures. The major adverse event (MAE) rate was equivalent to conventional balloon angioplasty treatment at its six-month follow-up point, as reported by the trial's national principal investigator, Michael Dake, M.D., professor and chairman of the department of radiology at the University of Virginia Health System.

Feb. 1, 2007 — Royal Philips Electronics has announced the commercial release of its new EP Navigator, which Philips calls an easy-to-use, innovative imaging tool to support clinicians in the treatment of complex cardiac rhythm disorders.

EP Navigator combines pre-interventional 3D CT images of a patients’ cardiac anatomy with live X-ray fluoroscopy catheter position information in a single image. The result is easier navigation through the heart during complex procedures, enabling physicians to work more intuitively and with greater confidence.

Feb. 1, 2007 - New data shows that a year after undergoing carotid angioplasty and stenting, a minimally invasive treatment to prevent stroke, nearly half of patients (43 percent) showed statistically significant improvement in brain function, such as memory, judgement and reasoning. Those are the findings of a study being presented at the International Symposium on Endovascular Therapy (ISET).

Jan. 31, 2007 — Boston Scientific Corp. days it has received FDA 510(k) clearance to expand its PolarCath Peripheral Dilatation System offering to include a 100mm balloon.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now